Search Results 211-220 of 17445 for bisphosphonates side effects

  1. Dalteparin (subcutaneous route) - Side effects & dosage - Mayo Clinic

    These blood clots can travel to the lungs and can become lodged in the blood vessels of the lungs, causing a condition called pulmonary embolism. This medicine ...

  2. Medicines that increase fall risk in older adults - Mayo Clinic

    Taking certain antidepressants increases the risk of falls due to their sedative side effects. Taking more than one makes the risk even higher. Medicines used ...

  3. Empagliflozin and metformin (oral route) - Side effects & dosage - Mayo Clinic

    It is also used to lower the risk of cardiovascular death in patients with type 2 diabetes and heart or blood vessel disease. This medicine is also used to ...

  4. Women's Wellness: Bone density in women - Mayo Clinic News Network

    Serious side effects are rare, and much lower than the absolute risk of a hip fracture in an untreated individual. Learn more: Mayo Clinic Minute: Exercise ...

  5. Pembrolizumab, Lenalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplant - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. ... Negative pregnancy test done =< 7 days prior to ... NOTE: Bisphosphonates are considered to be ...

  6. Fluticasone and salmeterol (inhalation route) - Mayo Clinic

    To do so may increase the chance of side effects. In order for this medicine to help prevent asthma attacks, it must be used every day in regularly spaced doses ...

  7. Valganciclovir (oral route) - Mayo Clinic

    Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for ...

  8. Bexagliflozin (oral route) - Mayo Clinic

    Weakened physical condition (due to illness or surgery)—May increase risk for more serious side effects. Blood vessel disease or; Diabetic foot ulcer or; Leg ...

  9. A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase ... Stable standard dosing of bisphosphonate and denosumab as indicated for ...

  10. Study of INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase ... bisphosphonate therapy or denosumab. Participating Mayo Clinic ...